Drug Trial Radar · NCT07005752
A Study to Evaluate the Efficacy and Safety of CnU Capsule 750 mg in Patients With Cholesterol Gallstones(GB Stones).
Last checked: Nov 19, 2026Latest source record: Jul 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
484
Planned (sponsor's estimate)
Start
Jul 28, 2025
Primary completion
Nov 10, 2027
Study completion Jun 13, 2028
Sponsor
- Lead sponsor
- Myungmoon Pharma. Co. Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jun 5, 2025
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 19 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this clinical trial is to evaluate the efficacy and safety of CnU capsule 750 mg administration in patients with Cholesterol gallstone (radiolucent gallstones)
Conditions
- Cholesterol Cholelithiasis
Interventions
CnU cap. 250mg & Ursa placebo tab. 200mgDrug
CnU capsule(Magnesium Salt Trihydrate of Chenodeoxycholic Acid and Ursodeoxycholic Acid) and Ursa placebo tablet will be orally administered three times a day after meals at regular intervals for a total of 24 weeks.
Ursa tab. 200mg & CnU placebo cap. 250mgDrug
Ursa tablet(Ursodeoxycholic Acid) and CnU placebo capsule will be orally administered three times a day after meals at regular intervals for a total of 24 weeks.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Response to dissolution therapyTime frame: From baseline to the end of treatment at 24 weeks
Locations
13 sites in 1 country. Site status is shown where the registry gives one.
Pusan National University Hospital
Busan, South Korea · Recruiting
Kyungpook National University Hospital
Daegu, South Korea · Recruiting
CHA Bundang Medical Center
Gyeonggi-do, South Korea · Recruiting
Hallym University Dongtan Sacred Heart Hospital
Gyeonggi-do, South Korea · Recruiting
Soonchunhyang University Cheonan Hospital
Gyeonggi-do, South Korea · Recruiting
Inha University Hospital
Incheon, South Korea · Recruiting
Inje University Sanggye Paik Hospital
Seoul, South Korea · Recruiting
Kangbuk Samsung Hospital
Seoul, South Korea · Recruiting
Eunpyeong St. Mary's Hospital, The Catholic University of Korea
Seoul, South Korea · Recruiting
Gangnam Severance Hospital
Seoul, South Korea · Recruiting
Korea University Ansan Hospital
Ansan, Gyeonggi-do, South Korea · Recruiting
Soonchunhyang University Bucheon Hospital
Bucheon-si, Gyeonggi-do, South Korea · Recruiting
Ajou University Hospital
Suwon, Gyeonggi-do, South Korea · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.